These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 710453)

  • 21. Effect of age on the detection rate in Duchenne muscular dystrophy.
    Zatz M; Otto PA
    J Neurol Sci; 1980 Sep; 47(3):407-10. PubMed ID: 7420114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Differential diagnosis of Becker and Duchenne muscular dystrophy].
    Alvarez Leal M; Hernández Sifuentes PM; Pérez-Zuno JA
    Gac Med Mex; 1994; 130(6):454-8. PubMed ID: 7557060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diminished cap formation in lymphocytes from patients and carriers of Duchenne muscular dystrophy.
    Verrill HL; Pickard NA; Gruemer HD
    Clin Chem; 1977 Dec; 23(12):2341-3. PubMed ID: 923085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variability of serum creatine phosphokinase activity in normal women and carriers of the gene for Duchenne muscular dystrophy.
    Perry TB; Fraser FC
    Neurology; 1973 Dec; 23(12):1316-23. PubMed ID: 4796611
    [No Abstract]   [Full Text] [Related]  

  • 25. Duchenne muscular dystrophy carrier detection using logistic discrimination: serum creatine kinase and hemopexin in combination.
    Percy ME; Andrews DF; Thompson MW
    Am J Med Genet; 1981; 8(4):397-409. PubMed ID: 7246612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myoglobinemia in Duchenne muscular dystrophy carriers.
    Ando T; Kato T; Ohsawa M; Fukuyama Y
    Brain Dev; 1980; 2(1):87-8. PubMed ID: 7416442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myoglobinaemia in Duchenne muscular dystrophy patients and carriers: A new adjunct to carrier detection.
    Adornato BT; Kagen LJ; Engel WK
    Lancet; 1978 Sep; 2(8088):499-501. PubMed ID: 79868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Echinogenic action of L-alpha-lysophosphatidylcholine in Duchenne muscular dystrophy: a study on carrier detection.
    Tangorra A; Curatola G; Milani-Comparetti M; Ferretti G
    Am J Med Genet; 1989 Apr; 32(4):540-4. PubMed ID: 2774000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neonatal screening for duchenne myopathy by serum elevation of creatine phosphokinase activity. 5 years experience].
    Plauchu H; Dellamonica C; Pascal B; Jolivet MJ; Guibaud P; Cotte J; Robert JM
    J Genet Hum; 1981 Mar; 29(1):59-69. PubMed ID: 7334342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative EMG and histological carrier detection of Duchenne muscular dystrophy.
    Scarlato G; Valli G; Meola G; Carenini L
    J Neurol; 1977 Nov; 216(4):235-49. PubMed ID: 72807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of carriers and genetic counseling in duchenne muscular dystrophy by ribosomal protein synthesis.
    Ionasescu V; Zellweger H; Burmeister L
    Acta Neurol Scand; 1976 Nov; 54(5):442-52. PubMed ID: 998168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New CPK mass screening test in the early diagnosis of muscular diseases].
    Beckmann R; Scheuerbrandt G; Antonik A; Antonik S
    Fortschr Med; 1974 Nov; 92(33):1348-54. PubMed ID: 4457445
    [No Abstract]   [Full Text] [Related]  

  • 33. Symptomatic carriers of muscular dystrophy.
    Azam M
    J Pak Med Assoc; 1997 Mar; 47(3):89-93. PubMed ID: 9131861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Enzyme diagnosis in progressive muscular dystrophies, especially in the Duchenne type].
    Pernice W; Beckmann R; Renner S; Wais U
    Klin Padiatr; 1989; 201(3):167-76. PubMed ID: 2739342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carrier detection in X-linked Becker muscular dystrophy by muscle provocation test (MPT).
    Herrmann FH; Spiegler AW
    J Neurol Sci; 1983 Dec; 62(1-3):141-6. PubMed ID: 6668470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Failure of fetal creatine phosphokinase as a diagnostic indicator of Duchenne muscular dystrophy.
    Golbus MS; Stephens JD; Mahoney MJ; Hobbins JC; Haseltine FP; Caskey CT; Banker BQ
    N Engl J Med; 1979 Apr; 300(15):860-1. PubMed ID: 423925
    [No Abstract]   [Full Text] [Related]  

  • 37. Serum alpha-galactosidase activity in children with Duchenne-type muscular dystrophy and in gene carriers.
    László A; Havass Z
    Acta Paediatr Hung; 1983; 24(4):327-9. PubMed ID: 6324830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The contribution of assays for lymphocyte capping and creatine kinase to detection of the Becker-type dystrophy trait.
    Goldsmith BM; Gruemer HD; Hawley RJ; Pickard NA; Verrill HL; Nance WE; Miller G; Crawford RG
    Clin Chem; 1980 May; 26(6):754-9. PubMed ID: 7371153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum pyruvate kinase in different neuromuscular diseases and in carriers of muscular dystrophy.
    Savonitto C; Bonadonna G; Bongiovanni LG; Duso E; De Grandis D
    Ital J Neurol Sci; 1983 Dec; 4(4):417-22. PubMed ID: 6674240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Serum enzymatic activity in neuromuscular diseases].
    Strumień M
    Neurol Neurochir Pol; 1975; 9(1):1-5. PubMed ID: 1121344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.